COMPARATIVE EVALUATION OF THE EFFICIENCY OF THE USE OF BETAXOLOL AND TIMOLOL IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA

Аннотация

Introduction. For many decades and to the present day, glaucoma has been one of the leading causes of
blindness in the world. According to some authors, about 1.7% of the population over the age of 40 suffer from this
disease. In most countries of the world, glaucoma leads to irreversible blindness in 5–33% of cases [2]. Its prevalence
continues to grow along with population growth and increasing life expectancy. This problem is especially relevant
for Russia, because in recent years, for a number of subjective and objective reasons, the number of patients with
glaucoma has increased more than three times, and the level of blindness and disability due to this disease has
changed accordingly [1]. Moreover, POAG, which is latent and often diagnosed in the later stages, accounts for 80%
of other varieties of this disease.